Hemostemix Inc. (CVE:HEM – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.05 and traded as high as C$0.09. Hemostemix shares last traded at C$0.09, with a volume of 92,000 shares trading hands.
Hemostemix Price Performance
The business has a 50 day simple moving average of C$0.05 and a 200 day simple moving average of C$0.05. The stock has a market cap of C$7.41 million, a PE ratio of -4.25 and a beta of 0.15.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States.
Read More
- Five stocks we like better than Hemostemix
- What is a Dividend King?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- What is the Euro STOXX 50 Index?
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Best Stocks Under $5.00
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
